Funded Tech Companies
Biohaven Pharmaceuticals
Looking for the VC firms that invested in Biohaven Pharmaceuticals? Vivo Capital, Aisling Capital and Venrock invested in this innovative biopharmaceutical company.
Company Overview
Company Name
Biohaven Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
215 Church St.
New Haven, CT 06510
USA
New Haven, CT 06510
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Biohaven Pharmaceuticals (NYSE: BHVN) is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/4/2017
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vlad Coric
Chief Financial Officer
James Engelhart
Chief Medical Officer
Robert Berman
Chief Scientific Officer
Charlie Conway
Controller
David Loomis
VP - Bus. Development
Robert Croop
VP - Bus. Development
Donnie McGrath
VP - Bus. Development
Elyse Stock
VP - Operations
Lia Donahue
VP - Operations
Kim Gentile
VP - Operations
Meghan Lovegren
VP - Operations
Beth Morris
VP - Regulatory Affairs
Marianne Frost
Company Investors
- Vivo Capital
- Aisling Capital
- Venrock (Nimish Shah)
- Rock Springs Capital
- Osage Partners
- Aperture Venture Partners
- RA Capital
- Connecticut Innovations
- Knollwood Investment Advisory
- Private Investors (Greg Bailey)
- Private Investors (John Childs)
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs